Edition:
United States

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

15.68USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$15.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,875
52-wk High
$31.75
52-wk Low
$14.94

Chart for

About

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients... (more)

Overall

Beta: --
Market Cap(Mil.): $448.28
Shares Outstanding(Mil.): 26.89
Dividend: --
Yield (%): --

Financials

  ODT.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -2.44 -- --
ROI: -- 13.18 12.83
ROE: -- 15.14 14.95

Earnings vs. Estimates